Skip to main content

LOGAN CAPITAL MANAGEMENT INC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1121330 Newtown Square, PA

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$598,523
+$598,523 QoQ
Shares Held
41,306
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#100
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Derivatives in RDY

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$569,235
PutShares
41,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LOGAN CAPITAL MANAGEMENT INC holds $3,471,535 across 5 Drug Manufacturers - Specialty & Generic names. RDY ranks #3 (17.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 RDY
Dr Reddys Laboratories Ltd
This page
41,306 $598,523

All Filings in RDY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $598,523 41,306
2026-03-31 $569,235 41,100
2025-12-31 $577,044 41,100
2025-09-30 $574,578 41,100
2025-06-30 $246,942 16,430
2025-03-31 $540,394 40,970
2024-12-31 $664,206 42,065
2024-09-30 $994,316 12,515
2024-06-30 $957,403 12,566
2024-03-31 $916,508 12,495
2023-12-31 $865,923 12,445
2023-09-30 $788,932 11,798
2023-06-30 $744,571 11,798
2023-03-31 $1,029,919 18,091
2022-12-31 $936,208 18,091
2022-09-30 $1,014,714 19,387
2022-06-30 $1,069,801 19,314
2022-03-31 $1,119,057 20,080
2021-12-31 $987,493 15,097
2021-09-30 $1,340,059 20,572
2021-06-30 $1,187,186 16,150
2021-03-31 $907,650 14,785
2020-12-31 $1,057,729 14,837
2020-09-30 $1,020,862 14,676
2020-06-30 $566,994 10,696
2020-03-31 $431,369 10,696